BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3551883)

  • 21. [Clinical research on the hypolipidemic action of a probucol preparation].
    Naumova R; Kerekovska M; Goranov I; Balabanski L
    Vutr Boles; 1986; 25(2):73-7. PubMed ID: 3716382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Probucol treatment of hyperlipidemia].
    Koizumi J
    Nihon Rinsho; 1994 Dec; 52(12):3279-84. PubMed ID: 7853723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of probucol on cholesterol and lipoprotein metabolism in man.
    Kesäniemi YA; Grundy SM
    J Lipid Res; 1984 Aug; 25(8):780-90. PubMed ID: 6491523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Behavior of high-density lipoproteins in drug lipid-lowering treatment].
    Mordasini R; Riesen W; Oster P; Riva G
    Schweiz Med Wochenschr; 1982 Jan; 112(3):95-8. PubMed ID: 7058319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Curcumin attenuates diet-induced hypercholesterolemia in rats.
    Arafa HM
    Med Sci Monit; 2005 Jul; 11(7):BR228-234. PubMed ID: 15990684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lipoprotein cholesterol in the blood plasma of rats with a bile circulation disorder].
    Finagin LK; Litovka IG
    Fiziol Zh (1978); 1989; 35(4):103-5. PubMed ID: 2792431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysophosphatidylcholine molecular species in low density lipoprotein and high density lipoprotein in alloxan-induced diabetic rats: effect of probucol.
    Shi A; Yoshinari M; Iino K; Wakisaka M; Iwase M; Fujishima M
    Exp Clin Endocrinol Diabetes; 1999; 107(6):337-42. PubMed ID: 10543409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discrepancies between the outcome of animal and human studies on the mode of action of probucol.
    Beynen AC
    Atherosclerosis; 1986 Sep; 61(3):249-51. PubMed ID: 3768092
    [No Abstract]   [Full Text] [Related]  

  • 29. [How do changes in the plasma concentration of HDL induced by probucol operate?].
    Med Clin (Barc); 1988 Apr; 90(13):556-7. PubMed ID: 3393042
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mechanism of action of hypolipemic drugs].
    Fruchart JC
    J Pharm Belg; 1992; 47(4):345-50. PubMed ID: 1403601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of probucol on hypercholesterolemia in renal transplant patients.
    Okubo M; Nakamura M; Horii A; Kamata K; Takeuchi Y; Tsukamoto Y; Kobayashi N; Sato K; Endo T
    Kidney Int Suppl; 1999 Jul; 71():S229-30. PubMed ID: 10412784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and therapeutic use of probucol.
    Berg A; Baumstark MW; Frey I; Halle M; Keul J
    Eur J Clin Pharmacol; 1991; 40 Suppl 1():S81-4. PubMed ID: 2044650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of the hyperlipidemia of the nephrotic syndrome: a controlled trial.
    Valeri A; Gelfand J; Blum C; Appel GB
    Am J Kidney Dis; 1986 Dec; 8(6):388-96. PubMed ID: 3544820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probucol, a new cholesterol lowering drug.
    Nash DT
    J Med; 1975; 6(5-6):305-15. PubMed ID: 768396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colestipol and probucol: treatment of primary and familial hypercholesterolemia and amelioration of atherosclerosis.
    Glueck CJ
    Ann Intern Med; 1982 Apr; 96(4):475-82. PubMed ID: 7039445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cholesterol and bile acid dynamics: comparative aspects].
    Lutton C
    Reprod Nutr Dev; 1990; 30(2):145-60. PubMed ID: 2190572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probucol in long-term treatment of hypercholesterolemia.
    Strandberg TE; Vanhanen H; Miettinen TA
    Gen Pharmacol; 1988; 19(3):317-20. PubMed ID: 3046993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of familial and non-familial hypercholesterolaemia: a review of HMG-CoA reductase inhibitors and probucol.
    Tikkanen MJ; Helve E; Nikkilä EA
    Eur Heart J; 1987 Aug; 8 Suppl E():97-101. PubMed ID: 3315684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of probucol on the composition of lipoproteins and on VLDL apoprotein B turnover.
    Lock DR; Kuisk I; Gonen B; Patsch W; Schonfeld G
    Atherosclerosis; 1983 Jun; 47(3):271-8. PubMed ID: 6882500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemia.
    Cortese C; Marenah CB; Miller NE; Lewis B
    Atherosclerosis; 1982 Sep; 44(3):319-25. PubMed ID: 7150396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.